Incidence, survival and mortality rates of stage-specific bladder cancer in United States: A trend analysis

Cancer Epidemiology

Volumn 37, Issue 3, 2013, Pages 219-225

  Abdollah, Firas ^a,b   Gandaglia, Giorgio ^a,b   Thuret, Rodolphe ^a,c   Schmitges, Jan ^a,d   Tian, Zhe ^a   Jeldres, Claudio ^a   Passoni, Niccolò Maria ^b   Briganti, Alberto ^b   Shariat, Shahrokh F ^e   Perrotte, Paul ^a   Montorsi, Francesco ^b   Karakiewicz, Pierre I ^a   Sun, Maxine ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIV MONTPELLIER   (France)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Incidence; Neoplasm staging; SEER program statistics numerical data; Survival analysis; Urinary bladder neoplasms mortality

Indexed keywords

AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SURVIVAL RATE; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASM STAGING; SEER PROGRAM; SURVIVAL RATE; UNITED STATES; URINARY BLADDER NEOPLASMS;

EID: 84876305104     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.02.002     Document Type: Article

References (35)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA: A Cancer Journal for Clinicians 2010, 60(5):277-300.
2. Brookfield K.F., Cheung M.C., Gomez C., Yang R., Nieder A.M., Lee D.J., et al. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer 2009, 115(18):4196-4209.
3. Mallin K., David K.A., Carroll P.R., Milowsky M.I., Nanus D.M. Transitional cell carcinoma of the bladder: racial and gender disparities in survival (1993 to 2002), stage and grade (1993 to 2007). Journal of Urology 2011, 185(5):1631-1636.
4. Prout G.R., Wesley M.N., Greenberg R.S., Chen V.W., Brown C.C., Miller A.W., et al. Bladder cancer: race differences in extent of disease at diagnosis. Cancer 2000, 89(6):1349-1358.
5. Ward E.M., Fedewa S.A., Cokkinides V., Virgo K. The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer Journal 2010, 16(6):614-621.
6. Leissner J., Hohenfellner R., Thuroff J.W., Wolf H.K. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU International 2000, 85(7):817-823.
7. Hussain M.H., Wood D.P., Bajorin D.F., Bochner B.H., Dreicer R., Lamm D.L., et al. Bladder cancer: narrowing the gap between evidence and practice. Journal of Clinical Oncology 2009, 27(34):5680-5684.
8. Dhar N.B., Klein E.A., Reuther A.M., Thalmann G.N., Madersbacher S., Studer U.E. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. Journal of Urology 2008, 179(3):873-878. discussion 878.
9. Lamm D.L., Blumenstein B.A., Crawford E.D., Montie J.E., Scardino P., Grossman H.B., et al. A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guerin for transitional-cell carcinoma of the bladder. New England Journal of Medicine 1991, 325(17):1205-1209.
10. Lamm D.L., Blumenstein B.A., David Crawford E., Crissman J.D., Lowe B.A., Smith J.A., et al. Randomized intergroup comparison of bacillus Calmette-Guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study. Urologic Oncology 1995, 1(3):119-126.
11. Underwood W., Dunn R.L., Williams C., Lee C.T. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. Journal of the American College of Surgeons 2006, 202(2):284-290.
12. Scosyrev E., Noyes K., Feng C., Messing E. Sex and racial differences in bladder cancer presentation and mortality in the US. Cancer 2009, 115(1):68-74.
13. Prout G.R., Wesley M.N., McCarron P.G., Chen V.W., Greenberg R.S., Mayberry R.M., et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer 2004, 100(3):621-630.
14. Pollack A., Zagars G.K., Cole C.J., Dinney C.P., Swanson D.A., Grossman H.B. The relationship of local control to distant metastasis in muscle invasive bladder cancer. Journal of Urology 1995, 154(6):2059-2063. discussion 2063-4.
15. Gore J.L., Litwin M.S., Lai J., Yano E.M., Madison R., Setodji C., et al. Use of radical cystectomy for patients with invasive bladder cancer. Journal of the National Cancer Institute 2010, 102(11):802-811.
16. SEER. Surveillance epidemiology and end results. ; 2010. http://seer.cancer.gov/about/.
17. Zippin C., Lum D., Hankey B. Completeness of hospital cancer case reporting from the SEER program of the National Cancer Institute. Cancer 1995, 76(11):2343-2350.
18. Kim H., Fay M., Feuer E., Midthune D. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in Medicine 2000, 19(3):335-351.
19. Devesa S.S., Donaldson J., Fears T. Graphical presentation of trends in rates. American Journal of Epidemiology 1995, 141:300-304.
20. Taylor B.C., Wilt T.J., Fink H.A., Lambert L.C., Marshall L.M., Hoffman A.R., et al. Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study. Urology 2006, 68(4):804-809.
21. Measurement of Progress Against Cancer Extramural committee to assess measures of progress against cancer. Journal of the National Cancer Institute 1990, 82(10):825-835.
22. Welch H.G., Schwartz L.M., Woloshin S. Are increasing 5-year survival rates evidence of success against cancer?. Journal of the American Medical Association 2000, 283(22):2975-2978.
23. Bailar J.C., Gornik H.L. Cancer undefeated. New England Journal of Medicine 1997, 336(22):1569-1574.
24. Chow W.H., Devesa S.S. Contemporary epidemiology of renal cell cancer. Cancer Journal 2008, 14(5):288-301.
25. Chow W.H., Devesa S.S., Warren J.L., Fraumeni J.F. Rising incidence of renal cell cancer in the United States. Journal of the American Medical Association 1999, 281(17):1628-1631.
26. Elias K., Svatek R.S., Gupta S., Ho R., Lotan Y. High-risk patients with hematuria are not evaluated according to guideline recommendations. Cancer 2010, 116(12):2954-2959.
27. Mungan N.A., Kiemeney L.A., van Dijck J.A., van der Poel H.G., Witjes J.A. Gender differences in stage distribution of bladder cancer. Urology 2000, 55(3):368-371.
28. Najari B.B., Rink M., Li P.S., Karakiewicz P.I., Scherr D.S., Shabsigh R., et al. Sex disparities in cancer mortality: the risks of being a man in the United States. Journal of Urology 2012, 10.1016/j.juro.2012.11.153.
29. Mungan N.A., Aben K., Schoenberg M., Visser O., Coebergh J., Witjes J., et al. Gender differences in stage-adjusted bladder cancer survival. Urology 2000, 55(6):876-880.
30. Donat S.M. Integrating perioperative chemotherapy into the treatment of muscle-invasive bladder cancer: strategy versus reality. Journal of the National Comprehensive Cancer Network 2009, 7(1):40-47.
31. David K.A., Mallin K., Milowsky M.I., Ritchey J., Carroll P.R., Nanus D.M. Surveillance of urothelial carcinoma: stage and grade migration, 1993-2005 and survival trends, 1993-2000. Cancer 2009, 115(7):1435-1447.
32. Nieder A.M., Mackinnon J.A., Huang Y., Fleming L.E., Koniaris L.G., Lee D.J. Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease. Journal of Urology 2008, 179(2):491-495. discussion 495.
33. Gandini S., Botteri E., Iodice S., Boniol M., Lowenfels A.B., Maisonneuve P., et al. Tobacco smoking and cancer: a meta-analysis. International Journal of Cancer 2008, 122(1):155-164.
34. Reulen R.C., Kellen E., Buntinx F., Brinkman M., Zeegers M.P. A meta-analysis on the association between bladder cancer and occupation. Scandinavian Journal of Urology and Nephrology: Supplementum 2008, (Sep (218)):64-78.
35. Koebnick C., Michaud D., Moore S.C., Park Y., Hollenbeck A., Ballard-Barbash R., et al. Body mass index: physical activity, and bladder cancer in a large prospective study. Cancer Epidemiology, Biomarkers & Prevention 2008, 17(5):1214-1221.